The vaccine appears to be safe and effective against triple-negative breast cancer -- a type that can’t be treated with ...

A judge has found that the man charged with shooting and wounding three college students of Palestinian descent in Vermont ...

The CFPB has long been a target of Republicans, who argue the agency under Director Rohit Chopra oversteps its legal ...

A federal judge ruled Wednesday that Meta must face trial in an antitrust case brought by the Federal Trade Commission (FTC) ...

Facebook owner Meta Platforms must face trial in a U.S. Federal Trade Commission lawsuit seeking its break-up over claims ...

Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss ...

We’ve learned this lesson the hard way. Consumer Reports buys dozens of new cars every year for testing, and a few of them ...

Tesla's stock price soared after the tweets and then fell again after Aug. 17, 2018, as it became clear the buyout would not ...

LONDON (Reuters) - Online fast-fashion platforms Shein and Temu are gearing up for a 2026 trial at London's High Court, with ...

Though it may seem like something from the future, these five cancer vaccines are available now. Here, more details on who is eligible for each.

Europe has lost command over pharmaceutical clinical trials over the last decade at the expense the market leading US and exponential growth in China, according to a new report by healthcare data ...

Amplia Therapeutics Ltd. (AU:ATX) has released an update. Amplia Therapeutics has reported promising interim results from its ACCENT trial, testing the drug narmafotinib in combination with ...